Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 13;29:101206. doi: 10.1016/j.bbrep.2022.101206

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 3 — DND1 is significantly co-expressed with other genes in a variety of human cancers. (A) The percentage of genes that are positively (orange bars) or negatively (blue bars) co-expressed with DND1 in a variety of human cancers with q value less than 0.01. (B) Summary of the number of total genes that are expressed in a variety of human cancers, the number and percentage of genes that are significantly positively or negatively co-expressed with DND1, as well as the ratio between them (Pos/Neg). BIC, breast invasive carcinoma; BUC, bladder urothelial carcinoma; CA, colorectal adenocarcinoma; GBM, glioblastoma; HCC, hepatocellular carcinoma; LA, lung adenocarcinoma; LSCC, lung squamous cell carcinoma; OSC, ovarian serous cystadenocarcinoma; PanA, pancreatic adenocarcinoma; ProA, prostate adenocarcinoma; RCCC, renal clear cell carcinoma; RPCC, renal papillary cell carcinoma; SA, stomach adenocarcinoma; SCM, skin cutaneous melanoma; TGCT, testicular germ cell tumor. SCEG, significantly co-expressed genes. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)